From the Journals

Novel biomarker test appears accurate for UTI diagnosis in febrile children under 2 years


 

FROM PEDIATRICS

Novel test for the urinary neutrophil gelatinase–associated lipocalin (uNGAL) biomarker have good sensitivity and specificity to distinguish whether infants and children younger than 2 years old have a urinary tract infection (UTI), said Tamar R. Lubell, MD, and her associates at Columbia University, New York.

“NGAL is a protein expressed in neutrophils and several other human tissues, including alpha-intercalated cells in the collecting duct of the kidney,” the researchers explained. “The urine and serum contain very low levels of NGAL protein at steady state, with expression of NGAL rising rapidly in response to cell damage caused by ischemia-reperfusion injury, presence of cytotoxins, and sepsis.”

A jar containing a urine sample copyright toeytoey2530/Thinkstock
This prospective study was performed in an urban, tertiary care, pediatric emergency department between August 2013 and October 2015. Children were included if they presented with fever that was greater than or equal to 100.4° F for infants younger than 3 months and greater than or equal to 102.2° F for children aged 3-24 months.

Of the 260 children whose catheterized urine was analyzed, 14% had UTIs. For the diagnosis of UTI in febrile children younger than age 2 years, uNGAL testing had a sensitivity of 97% and a specificity of 96%. The median uNGAL concentration was 215.1 ng/mL in the UTI group, compared with 4.4 ng/mL in the culture-negative group. Urinalysis and Gram stain also were performed.

“uNGAL had higher sensitivity than [urinalysis], with similar specificity,” the investigators said. “Gram stain had a somewhat lower sensitivity than uNGAL, but with high specificity.”

The researchers identified a cutoff point for uNGAL levels to be 39.1 ng/mL. A previous case-control study of 108 infants with UTI had a cutoff for uNGAL levels of 38 ng/mL, with sensitivity of 93% and specificity of 95%. Most urine samples in that study were obtained by clean catch rather than by catheterization, as in the current study.

“Further studies will need to both confirm our findings and determine the benefit and cost effectiveness of uNGAL testing, compared with [urinalysis],” Dr. Lubell and her associates said.

Read more in Pediatrics (2017 Nov 16. doi: 10.1542/peds.2017-1090).

   Comments ()

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge